Iscador Qu inhibits doxorubicin-induced senescence of MCF7 cells
Author:
Publisher
Springer Science and Business Media LLC
Subject
Multidisciplinary
Link
http://www.nature.com/articles/s41598-017-03898-0.pdf
Reference142 articles.
1. Ferlay, J. et al. Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int. J. Cancer. 127, 2893–2917 (2010).
2. Gonzalez-Angulo, A. M., Morales-Vasquez, F. & Hortobagyi, G. N. Overview of resistance to systemic therapy in patients with breast cancer. Adv. Exp. Med. Biol. 608, 1–22 (2007).
3. Uy, G. B. et al. Breast cancer hormone receptor assay results of core needle biopsy and modified radical mastectomy specimens from the same patients. Clin Breast Cancer. 10, 154–159 (2010).
4. Reinert, T. & Barrios, C. H. Optimal management of hormone receptor positive metastatic breast cancer in 2016. Ther Adv Med Oncol. 7, 304–320 (2015).
5. Minotti, G., Menna, P., Salvatorelli, E., Cairo, G. & Gianni, L. Anthracyclines: molecular advances and pharmacologic developments in antitumor activity and cardiotoxicity. Pharmacol. Rev. 56, 185–229 (2004).
Cited by 16 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Mechanisms of Senescence in Cancer: Positive and Negative Aspects of Cancer Cells Senescence;Cellular Physiology and Biochemistry;2023-12-06
2. Antitumor Effect of Iscador on Breast Cancer Cell Lines with Different Metastatic Potential;International Journal of Molecular Sciences;2023-03-09
3. The Endocannabinoid System as a Target in Cancer: Status and Future Perspectives;Handbook of Cancer and Immunology;2023
4. Nutrition Interventions of Herbal Compounds on Cellular Senescence;Oxidative Medicine and Cellular Longevity;2022-04-27
5. The Impacts of Prepared Plasma-Activated Medium (PAM) Combined with Doxorubicin on the Viability of MCF-7 Breast Cancer Cells: A New Cancer Treatment Strategy;Reports of Biochemistry and Molecular Biology;2022-01-01
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3